ATA Partners with AAES for Facebook Live on Thyroid Cancer and Surgery

When: Wednesday, September 30^th, 2020 at 8-9PM ET/ 5-6PM PT
Where: AAES Facebook Page

Thyroid Research Award 2020

Dr. Cristina Montero-Conde was awarded a Bite Me Cancer research grant to discover novel molecular nodes involved in MTC development and evolution. View this video to hear more about Dr. Montero-Code's research.

Clinical Thyroidology for the Public
VOLUME 13 ISSUE 9 September 2020

In this issue, the studies ask the following questions:

• Are new chemotherapy drugs effective against anaplastic thyroid cancer?
• If you had a low risk papillary thyroid cancer, would you choose to monitor closely or to have surgery?
• How common is salivary gland damage after radioactive iodine therapy for thyroid cancer?
• Due positive thyroglobulin antibodies indicate a recurrence of thyroid cancer?
• Are there effective non-surgical options for the treatment of benign thyroid nodules?
  
• Is a fixed dose of radioactive iodine effective treatment for toxic multinodular goiters?
  

We welcome your feedback and suggestions. Let us know what you want to see in this publication.

Thyroid Health – The Official Blog of ATA

Read September's blog by Dr. Christian Nasar titled Molecular testing in thyroid nodules: it is all about risk of malignancy.

Hypothyroid Patient Understanding and Treatment Survey

Dr. Antonio Bianco and colleagues at the University of Chicago are looking to understand what "foggy brain" is. Many hypothyroid patients that are treated with different forms of thyroid hormone replacement therapy complain of "foggy brain". Unfortunately, this specific complaint is hard to comprehend and evaluate.

Please complete the survey to help them improve understanding and treatment of hypothyroidism. Your participation in this research project is completely voluntary. We expect this survey to be completed in 5 to 10 minutes. The survey is anonymous and no personal information will be retained or distributed.

AbbVie Announces New Program

AbbVie recently announced the SYNTHROID Delivers Program, a direct-to-patient pharmacy program that offers patients an option to receive Synthroid delivered at their home regardless of insurance coverage. Learn more today.

Patient Alliance Upcoming Events

Join in the World MCT8-AHDS Day on October 8, 2020 to help raise awareness for this disease.

The ThyCa 23^rd International Thyroid Cancer Survivors' Conference will take place virtually on October 23-25, 2020. Click here to learn more.

September is Thyroid Cancer Awareness Month

Thyroid cancer is a malignant tumor of the thyroid gland. It is relatively uncommon compared to other cancers. In the United States, it is estimated that in 2016 approximately 64,000 new patients will be diagnosed with thyroid cancer, compared to more than 240,000 patients with breast cancer and 135,000 patients with colon cancer. However, fewer than 2,000 patients die of thyroid cancer each year. In 2013, the last year for which statistics are available, over 630,000 patients were living with thyroid cancer in the United States.

TYPES OF THYROID CANCER:

Papillary and Follicular thyroid cancer

Medullary thyroid cancer

Anaplastic thyroid cancer